Global Pharma4 May 2020 12:54
"it has signed an agreement with a global Japanese pharmaceutical company to evaluate Valirx's therapeutic, VAL301, for the purpose to contemplate a potential future license, for its use in the treatment of endometriosis."
market cap with new shares values company at £4m only and now cashed up, new board and also talks of a JV for their other non-core assets